PAL, RAJESH
 Distribuzione geografica
Continente #
EU - Europa 7.518
NA - Nord America 350
AS - Asia 114
AF - Africa 21
OC - Oceania 1
Totale 8.004
Nazione #
IT - Italia 7.417
US - Stati Uniti d'America 346
SE - Svezia 45
CN - Cina 39
SG - Singapore 27
EG - Egitto 20
GB - Regno Unito 18
DE - Germania 17
IN - India 11
HK - Hong Kong 8
VN - Vietnam 8
ES - Italia 5
CA - Canada 4
CZ - Repubblica Ceca 4
JP - Giappone 4
TR - Turchia 4
FI - Finlandia 3
IQ - Iraq 3
IR - Iran 3
TW - Taiwan 3
BE - Belgio 2
FR - Francia 2
KR - Corea 2
NL - Olanda 2
UA - Ucraina 2
BD - Bangladesh 1
LT - Lituania 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
Totale 8.004
Città #
Cagliari 6.990
Uta 329
Chandler 46
Nyköping 39
Boardman 32
Fairfield 23
Wilmington 22
Woodbridge 22
Ashburn 20
Seattle 20
Tanta 20
Singapore 19
Shanghai 17
Cambridge 15
Santa Clara 12
Mountain View 11
Nuoro 10
Rome 10
Houston 9
Dong Ket 8
Sassari 8
London 7
Torino 7
Ann Arbor 6
Boston 6
Heidelberg 6
Beijing 5
Los Angeles 5
Compostela 4
Hereford 4
Hillsboro 4
New York 4
Serramanna 4
Toronto 4
Brookline 3
Guangzhou 3
Helsinki 3
Istanbul 3
Pune 3
Quartucciu 3
Assèmini 2
Augusta 2
Bethesda 2
Brussels 2
Daejeon 2
Dearborn 2
Ghaziabad 2
Gioia Del Colle 2
Hong Kong 2
Jacksonville 2
Kanpur 2
Kashiwa 2
Lerici 2
Lucknow 2
Nanjing 2
Oakland 2
Paris 2
Phoenix 2
Redwood City 2
Rimini 2
Taipei 2
Taranto 2
Vodňany 2
Wandsworth 2
České Budějovice 2
Bhubaneswar 1
Bushehr 1
Central District 1
Centro 1
Changsha 1
Coulsdon 1
Dhaka 1
Falkenstein 1
Florence 1
Frankfurt am Main 1
Fremont 1
Jiaxing 1
Jinhua 1
Lagos 1
Lahore 1
Madrid 1
Milan 1
Munich 1
Norwalk 1
Paese 1
Plainsboro 1
Putignano 1
Regensburg 1
San Diego 1
San Francisco 1
San Jose 1
Southwark 1
Stockholm 1
Taizhou 1
Tampa 1
Tehran 1
Tempio Pausania 1
Wellington 1
Totale 7.849
Nome #
Antibacterial Activity and Molecular Docking Studies of a Selected Series of Hydroxy-3-arylcoumarins 3.274
Identification of new inhibitors against human Great wall kinase using in silico approaches 1.516
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 714
Exploring TEAD2 as a drug target for therapeutic intervention of cancer: a multi-computational case study 637
mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma 524
Diverse MicroRNAs-mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia 380
Deletion of Lactate Dehydrogenase-A Impairs Oncogene-Induced Mouse Hepatocellular Carcinoma Development 244
Comprehensive analysis of mRNA-miRNA network in preneoplastic hepatocytes undergoing regression following treatment with thyroid hormone. 239
Oncogene-dependent HCC metabolic reprogramming 178
INHIBITORY EFFECT OF LDHA KNOCK-OUT ON METABOLIC REPROGRAMMING IN C-MYC/H-RAS DRIVEN HEPATOCELLULAR CARCINOMA 164
Metabolic alterations of HCC are dependent upon different oncogene activation 161
Targeted inhibition of MASTL kinase activity induces apoptosis in breast cancer 7
Totale 8.038
Categoria #
all - tutte 11.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.175


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.159 0 0 0 0 460 331 179 39 16 41 35 58
2020/20211.934 61 120 98 465 339 217 116 143 56 116 137 66
2021/2022557 64 15 9 46 53 27 24 38 55 75 69 82
2022/20231.267 65 114 144 81 100 155 79 124 87 94 125 99
2023/20241.350 161 63 53 77 126 196 166 120 67 74 104 143
2024/20251.562 376 473 321 261 131 0 0 0 0 0 0 0
Totale 8.038